Sven H. Borho
@Orbimed Advisors Llc
Latest period2024 - Q3ReportedManaged Assets$5.504BTotal holdings113
Assets growth rate8.67%Assets growth rate (2-Q avg)0.72%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Orbimed Advisors Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 113 positions.
Assets under management
The assets under management (AUM) of Orbimed Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 5.504B in assets, with a quarterly growth rate of 8.67% and a 2-quarter average growth rate of 0.72%. The portfolio is managed by Sven H. Borho, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
EWTXEdgewise Therapeutics Inc
| 7.29% | $400.93M 15.022M shares@ $26.69 avg price | |
SVASinovac Biotech Ltd
| 6.18% | $340M 2.719M shares@ $125.06 avg price | |
LLYEli Lilly & Co
| 5.44% | $299.093M 337,600 shares@ $885.94 avg price | |
BSXBoston Scientific Corp
| 4.99% | $274.277M 3.273M shares@ $83.8 avg price | |
ISRGIntuitive Surgical Inc
| 3.88% | $213.113M 433,800 shares@ $491.27 avg price | Decreased -12.02% |
ELVNEnliven Therapeutics Inc
| 3.7% | $203.287M 7.96M shares@ $25.55 avg price | |
BIIBBiogen Inc
| 2.87% | $157.592M 813,000 shares@ $193.84 avg price | Decreased -9.75% |
MRKMerck & Co Inc
| 2.72% | $149.445M 1.316M shares@ $113.56 avg price | |
THCTenet Healthcare Corp
| 2.37% | $129.968M 782,000 shares@ $166.2 avg price | Decreased -33.35% |
SRPTSarepta Therapeutics Inc
| 2.28% | $125.452M 1.004M shares@ $124.89 avg price | Increased 44.33% |